Across all PDX models, there was a 5.2-fold reduction in SLFN11 expression in P2 tumours vs. P0 tumours, with the greatest difference (a 19.8-fold reduction) observed in ACS-HN04 (Figure 5C). This evidence concerns the gene SLFN11 and neoplasm.